Systemic lupus erythematosus linked to altered gut microbiome
The gut “microbiome”—all the micro-organisms that live in the human gut—is known to be altered in SLE patients. Now, a research team at Osaka University has comprehensively profiled the associations between the gut microbiome and SLE.
Intestinal ultrasound informs management of IBD
Point-of-care (POC) intestinal ultrasound (IUS) affects clinical decision-making in inflammatory bowel disease (IBD) and could reduce the need for endoscopy or magnetic resonance imaging (MRI), according to a study published online Oct. 12 in the Journal of Crohn's and Colitis.
How chronic intestinal inflammation can cause cancer
Chronic inflammatory bowel disease (IBD) are inflammations of the gastrointestinal tract which flare up in phases and are accompanied by bloody bowel movements, diarrhea and severe impairment of the quality of life.
AGA recommends change in testing protocol for cirrhosis patients
Patients with cirrhosis, or permanent liver damage, are at higher risk for coagulation disorders, which impact your body's ability to control blood clotting. The American Gastroenterological Association (AGA) has released new clinical guidelines to change how physicians identify and treat coagulation disorders in patients with cirrhosis.
Clinically active IBD linked to adverse COVID-19 outcomes
Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 27 in the Journal of Crohn's and Colitis.